HER2 Support Group Forums - View Single Post - Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with b

News · 02-09-2010, 01:23 AM

Amgen today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints.

More...

02-09-2010, 01:23 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,149	Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with b Amgen today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints. More...